Adenocarcinoma
|
group |
Neoplasms
|
Neoplastic Process
|
2235
|
168
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Anorexia
|
disease |
Pathological Conditions, Signs and Symptoms
|
Disease or Syndrome
|
242
|
10
|
0.100 |
None |
|
0 |
|
|
|
Antibody Deficiency Syndrome
|
disease |
Immune System Diseases
|
Disease or Syndrome
|
21
|
|
0.300 |
None |
1.000 |
1 |
|
1993 |
1993 |
Aortic Valve Insufficiency
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
377
|
8
|
0.010 |
None |
< 0.001 |
1 |
|
2017 |
2017 |
Autoimmune Diseases
|
group |
Immune System Diseases
|
Disease or Syndrome
|
1758
|
428
|
0.030 |
None |
0.667 |
3 |
|
1991 |
2014 |
Bare Lymphocyte Syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Immune System Diseases
|
Disease or Syndrome
|
24
|
|
0.300 |
None |
1.000 |
1 |
|
2004 |
2004 |
Carcinoma, Basal Cell
|
disease |
Neoplasms
|
Neoplastic Process
|
557
|
91
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Carcinoma, Ovarian Epithelial
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
2841
|
327
|
0.010 |
None |
1.000 |
1 |
|
1998 |
1998 |
Carcinoma, Transitional Cell
|
disease |
Neoplasms
|
Neoplastic Process
|
623
|
12
|
0.010 |
None |
1.000 |
1 |
|
2005 |
2005 |
Celiac Disease
|
disease |
Digestive System Diseases; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
527
|
263
|
0.010 |
None |
1.000 |
1 |
|
2003 |
2003 |
Childhood T Acute Lymphoblastic Leukemia
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
119
|
2
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Chronic oral candidiasis
|
disease |
Infections; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
8
|
2
|
0.100 |
None |
|
0 |
|
|
|
Decreased lymphocyte proliferation in response to mitogen
|
phenotype |
|
Cell or Molecular Dysfunction
|
13
|
|
0.100 |
None |
|
0 |
|
|
|
Decreased proportion of CD3-positive T cells
|
phenotype |
Immune System Diseases; Hemic and Lymphatic Diseases
|
Finding
|
9
|
|
0.100 |
None |
|
0 |
|
|
|
Diabetes
|
disease |
Endocrine System Diseases
|
Disease or Syndrome
|
2359
|
710
|
0.020 |
None |
1.000 |
2 |
|
2017 |
2018 |
Diabetes Mellitus
|
group |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
2803
|
824
|
0.020 |
None |
1.000 |
2 |
|
2017 |
2018 |
Diabetes Mellitus, Insulin-Dependent
|
disease |
Nutritional and Metabolic Diseases; Immune System Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
1675
|
954
|
0.020 |
None |
0.500 |
2 |
|
1991 |
2018 |
Endocervical adenocarcinoma
|
disease |
|
Neoplastic Process
|
14
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Endocervical Carcinoma
|
disease |
|
Neoplastic Process
|
14
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Eosinophilia
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
325
|
23
|
0.100 |
None |
|
0 |
|
|
|
Esophageal carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
1287
|
272
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Esophageal Neoplasms
|
group |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
1254
|
270
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Exfoliative dermatitis
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
64
|
2
|
0.100 |
None |
|
0 |
|
|
|
Experimental Organism Basal Cell Carcinoma
|
phenotype |
Neoplasms
|
Neoplastic Process
|
437
|
63
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Failure to thrive secondary to recurrent infections
|
phenotype |
|
Finding
|
7
|
|
0.100 |
None |
|
0 |
|
|
|